PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $47,000 | -55.2% | 227,797 | +2.2% | 0.00% | -100.0% |
| Q2 2019 | $105,000 | +483.3% | 222,886 | +434.4% | 0.00% | – |
| Q1 2019 | $18,000 | +157.1% | 41,706 | +76.7% | 0.00% | – |
| Q4 2018 | $7,000 | -75.0% | 23,606 | -38.5% | 0.00% | – |
| Q3 2018 | $28,000 | – | 38,356 | +10379.8% | 0.00% | – |
| Q3 2016 | $0 | – | 366 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 366 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 366 | -97.1% | 0.00% | – |
| Q2 2015 | $25,000 | -43.2% | 12,723 | -48.1% | 0.00% | -100.0% |
| Q1 2015 | $44,000 | +25.7% | 24,528 | +30.1% | 0.00% | 0.0% |
| Q4 2014 | $35,000 | -86.6% | 18,849 | -82.5% | 0.00% | -75.0% |
| Q3 2014 | $261,000 | -52.6% | 107,917 | -28.6% | 0.00% | -50.0% |
| Q2 2014 | $551,000 | +60.6% | 151,046 | +101.9% | 0.01% | +33.3% |
| Q1 2014 | $343,000 | +94.9% | 74,808 | +65.1% | 0.01% | +100.0% |
| Q4 2013 | $176,000 | -38.7% | 45,315 | -28.5% | 0.00% | -40.0% |
| Q3 2013 | $287,000 | +156.2% | 63,357 | +176.9% | 0.01% | +66.7% |
| Q2 2013 | $112,000 | – | 22,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|